Neuroone Medical Technologies Corp (NMTC)

Apr 23, 2025, 9:00 AM EDT - 3 days ago

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Apr 16, 2025, 9:00 AM EDT - 10 days ago

NeuroOne® Issues Letter to Shareholders

Apr 14, 2025, 9:00 AM EDT - 12 days ago

NeuroOne® OneRF® Technology Success Story Featured on Fox News

Apr 4, 2025, 12:57 PM EDT - 22 days ago

Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet

Apr 4, 2025, 8:30 AM EDT - 22 days ago

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

Apr 3, 2025, 4:05 PM EDT - 23 days ago

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

Mar 18, 2025, 1:12 PM EDT - 5 weeks ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - Update

Mar 18, 2025, 9:00 AM EDT - 5 weeks ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace

Mar 18, 2025, 8:46 AM EDT - 5 weeks ago

NeuroOne CEO Joins Today's Marketplace To Discuss The Latest Treatments for Epilepsy

Mar 11, 2025, 9:00 AM EDT - 6 weeks ago

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

Mar 5, 2025, 9:00 AM EST - 7 weeks ago

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Feb 12, 2025, 10:18 AM EST - 2 months ago

NeuroOne Medical Technologies Corporation (NMTC) Q1 2025 Earnings Call Transcript

Feb 12, 2025, 8:00 AM EST - 2 months ago

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update

Feb 5, 2025, 11:00 AM EST - 2 months ago

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

Feb 4, 2025, 10:56 AM EST - 2 months ago

NeuroOne® Regains Compliance with Nasdaq Listing Requirements

Jan 10, 2025, 8:30 AM EST - 3 months ago

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

Jan 7, 2025, 8:00 AM EST - 3 months ago

Stock Picks From Seeking Alpha's December 2024 New Analysts

ALGM CE CEG DOCS ETD FDVV FSS

Jan 3, 2025, 8:30 AM EST - 4 months ago

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST

Dec 17, 2024, 9:42 AM EST - 4 months ago

NeuroOne Medical Technologies Corporation (NMTC) Q4 2024 Earnings Call Transcript

Dec 17, 2024, 8:30 AM EST - 4 months ago

NeuroOne® Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025

Dec 10, 2024, 3:15 AM EST - 4 months ago

NeuroOne Medical Technologies: A Small-Cap Electrode Technology Play With Multiple Catalysts Ahead

Nov 13, 2024, 9:30 AM EST - 5 months ago

NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event

Oct 31, 2024, 4:01 PM EDT - 6 months ago

NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System

Sep 24, 2024, 9:30 AM EDT - 7 months ago

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

Sep 10, 2024, 9:00 AM EDT - 8 months ago

NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland

Sep 5, 2024, 6:23 PM EDT - 8 months ago

NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 14, 2024, 7:21 PM EDT - 9 months ago

NeuroOne Medical Technologies Corporation (NMTC) Q3 2024 Earnings Call Transcript

Aug 14, 2024, 4:00 PM EDT - 9 months ago

NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Aug 12, 2024, 11:30 AM EDT - 9 months ago

NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14

Jun 20, 2024, 9:30 AM EDT - 11 months ago

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

May 14, 2024, 9:48 PM EDT - 1 year ago

NeuroOne Medical Technologies Corporation (NMTC) Q2 2024 Earnings Call Transcript

May 14, 2024, 4:00 PM EDT - 1 year ago

NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

May 10, 2024, 2:43 PM EDT - 1 year ago

NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

Apr 10, 2024, 9:00 AM EDT - 1 year ago

NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology

Apr 9, 2024, 9:05 AM EDT - 1 year ago

NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes

Apr 4, 2024, 9:00 AM EDT - 1 year ago

NeuroOne® CEO Dave Rosa Featured on Fox Business Network's Varney & Co.

Mar 26, 2024, 9:00 AM EDT - 1 year ago

NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System

Mar 8, 2024, 12:00 PM EST - 1 year ago

NeuroOne® to Participate in the 36th Annual Roth Conference

Feb 23, 2024, 5:10 PM EST - 1 year ago

NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Feb 13, 2024, 8:04 PM EST - 1 year ago

NeuroOne Medical Technologies Corporation (NMTC) Q1 2024 Earnings Call Transcript

Feb 13, 2024, 4:00 PM EST - 1 year ago

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Feb 8, 2024, 3:30 PM EST - 1 year ago

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13

Dec 14, 2023, 6:30 PM EST - 1 year ago

NeuroOne Medical Technologies Corporation (NMTC) Q4 2023 Earnings Call Transcript

Dec 14, 2023, 4:15 PM EST - 1 year ago

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update

Dec 7, 2023, 4:30 PM EST - 1 year ago

NeuroOne® to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14

Nov 16, 2023, 8:00 AM EST - 1 year ago

NeuroOne® Announces Patent Allowance for Drug Delivery Utilizing a Novel Neural Probe

Nov 14, 2023, 5:15 PM EST - 1 year ago

NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Nov 14, 2023, 8:00 AM EST - 1 year ago

NeuroOne: A Hidden Contender Against ClearPoint In The Brain Drug Delivery Arena

CLPT

Oct 13, 2023, 9:30 AM EDT - 1 year ago

NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023

Sep 6, 2023, 4:00 PM EDT - 1 year ago

NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference